| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 11/27/2003 | WO2002094881A3 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 11/27/2003 | WO2002094195A3 Methods and compounds for the diagnosis of inflammatory disease and identification of pharmacological agents |
| 11/27/2003 | WO2002092771A3 Specific binding proteins and uses thereof |
| 11/27/2003 | WO2002089737A3 Separation of platelets from whole blood for use as a healant |
| 11/27/2003 | WO2002086156A3 New polynucleotides and polypeptides of the ifn$g(a)-17 gene |
| 11/27/2003 | WO2002086113A3 Enzyme and snp marker for disease |
| 11/27/2003 | WO2002085940A3 New polynucleotides and polypeptides of the erythropoietin gene |
| 11/27/2003 | WO2002083731A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 11/27/2003 | WO2002081490A3 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 11/27/2003 | WO2002077272A3 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders |
| 11/27/2003 | WO2002072632A3 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof. |
| 11/27/2003 | WO2002070006A8 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 11/27/2003 | WO2002068962A3 Determining cartilage degeneration and aging using bone morphogenic proteins |
| 11/27/2003 | WO2002066617A8 Method for detecting a risk of hypertension and uses thereof |
| 11/27/2003 | WO2002064825A3 Microelectronic array devices to perform multiplex immunoassay analysis |
| 11/27/2003 | WO2002064791A3 Proteins and nucleic acids encoding same |
| 11/27/2003 | WO2002062302A3 Steroidal derivatives |
| 11/27/2003 | WO2002061428A8 Method of disrupting interactions between biotin and biotin-binding compounds |
| 11/27/2003 | WO2002060950B1 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 11/27/2003 | WO2002059603A3 Microdevices containing photorecognizable coding patterns and methods of using and producing the same thereof |
| 11/27/2003 | WO2002057788A3 Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone |
| 11/27/2003 | WO2002057499A3 Mdr1 variants and methods for their use |
| 11/27/2003 | WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds |
| 11/27/2003 | WO2002048368A3 Proteins associated with cell growth, differentiation, and death |
| 11/27/2003 | WO2002029087A3 Use of lymphangiogenic agents to treat lymphatic disorders |
| 11/27/2003 | WO2001058926A3 Protein mapping |
| 11/27/2003 | WO2000062735A3 Treatment of neoplasms with viruses |
| 11/27/2003 | US20030221223 Producing genetically engineerered human blood protein such as hemoglobin, antitrypsin, fibrinogen and thrombin in monocot plant seed; veterinary medicine |
| 11/27/2003 | US20030221215 Comprises nucleotide sequences for preventing oomycete infection of potato and/or tomato; disease resistant plants |
| 11/27/2003 | US20030221205 Olfactory and pheromones G-protein coupled receptors |
| 11/27/2003 | US20030220777 Method and system for determining genotype from phenotype |
| 11/27/2003 | US20030220748 Computer-aided techniques for analyzing biological sequences |
| 11/27/2003 | US20030220746 Method and system for computing and applying a global, multi-channel background correction to a feature-based data set obtained from scanning a molecular array |
| 11/27/2003 | US20030220583 Portable diagnostic system |
| 11/27/2003 | US20030220502 A low molecular weight cyanine dye complexes, absorption spectra |
| 11/27/2003 | US20030220489 29 human secreted proteins |
| 11/27/2003 | US20030220484 Modified ciliary neurotrophic factors |
| 11/27/2003 | US20030220483 Comprises fibroblast growth factor homologous factor- 1 (FHF-1) for disgnosing, prevention and treatment of neurodegenerative or neoplastic disorders |
| 11/27/2003 | US20030220481 Liquid comprising receptor interacting protein death domain (RIP DD) for use as tool in discovery of antagonist of tumor necrosis factor signaling pathway |
| 11/27/2003 | US20030220473 An antitumor agent of polynucleotide sequence, a vector, a genetic construct, for encoding a protein |
| 11/27/2003 | US20030220471 Extracellular proteins coded by nucleic acids, receptor or membrane-bound proteins, amino acid sequence lacking the signal peptide; use as drugs as thrombolytic agents, interferons, interleukins, erythropoietins |
| 11/27/2003 | US20030220470 Methods for the purification of stable radioiodine conjugates |
| 11/27/2003 | US20030220316 Such as N-(1-(1-methylethyl)piperidin-4-yl)-N-((4-methyl phenyl)methyl)-4-methoxyphenylacetamide for stimulation of serotonin receptors |
| 11/27/2003 | US20030220306 Transcripts harboring inton 1, or fragment thereof; preventing or treating Alzheimer's Disease; ameliorating a neurodegenerative condition; modulating amyloid precursor protein; selectively inhibiting COX-3 or PCOX-1a activity |
| 11/27/2003 | US20030220281 To inhibit the activity of elastase or cathepsin G, thereby inhibiting ectopic implantation of endometrial fragments. |
| 11/27/2003 | US20030220246 Novel FGF homolog zFGF11 |
| 11/27/2003 | US20030220239 Epitope sequences |
| 11/27/2003 | US20030220232 Peptide with the sequence Gln-Tyr-Asn-Ala-Asp and derivatives differing from the original sequence by the addition, substitution, inversion, insertin, deletion or modification of one or more amino acids; sodium ion channel binder |
| 11/27/2003 | US20030220229 Modulate an immunological response by T cells of Type I diabetics which can be used as an indicator; derived from a region of proinsulin that spans the junction between the B chain and C peptide; inhibiting the development/progression |
| 11/27/2003 | US20030219910 Immunoassay method/equipment, biological component measurable toilet, anti-albumin monoclonal antibody, cell strain producing the same, and albumin detection kit |
| 11/27/2003 | US20030219908 An analytical test device for a competition binding, pregnancy testing; comprising a dry porous carrier for applying a liquid sample onto |
| 11/27/2003 | US20030219907 A controller for gas apparatus, monitoring the concentration of each components, comparing with the setpoint of the gas, displaying the readout |
| 11/27/2003 | US20030219905 Preparing sample for analysis, by breaking down protein in sample with enzyme solution to form peptides; purification |
| 11/27/2003 | US20030219904 Evaluating a platelet therapy by testing blood sample; anticoagulants |
| 11/27/2003 | US20030219893 Compositions and methods for the treatment of hepatitis C virus infection |
| 11/27/2003 | US20030219892 Illuminating the cells to obtain an image, determining the locations of specific individual cells, using energy beam to induce a response; detection, for drug delivery of genes into specific cells of interest |
| 11/27/2003 | US20030219891 An biological, optic apparatus for gene testing, optical sensor comprising pixels for detecting chemiluminescence between the reaction of biological sample and a reagent |
| 11/27/2003 | US20030219888 Binding enzyme, toxin with inorganic catalyst or fusion proteins which are contained in achromobacter cells, for using diagnositic, therapeutic, and drug screening |
| 11/27/2003 | US20030219885 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 11/27/2003 | US20030219884 Using laser beams to monitor and measuring electrical potential across transport/membrane proteins and/or g-protein coupled receptors; drug screening |
| 11/27/2003 | US20030219876 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell |
| 11/27/2003 | US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation |
| 11/27/2003 | US20030219873 Self-assembling recombinant papillomavirus capsid proteins |
| 11/27/2003 | US20030219860 Comprises nucleotide sequences coding novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents |
| 11/27/2003 | US20030219850 Method for automatically analyzing nucleated bone marrow cells |
| 11/27/2003 | US20030219849 Fluorescent phospholipase assay, phospholipase A2 inhibitor and stimulator, and the use thereof |
| 11/27/2003 | US20030219848 Comprises beta-galactosidase fragments for use as diagnostic tools in monitoring intracellular events; protein folding and solubility analysis |
| 11/27/2003 | US20030219845 Immunoassay for F1.2 prothrombin fragment |
| 11/27/2003 | US20030219844 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
| 11/27/2003 | US20030219843 Methods of diagnosing and treating abnormal growth |
| 11/27/2003 | US20030219842 Assays for cancer patient monitoring based on levels of epidermal growth factor receptor (EGFR) extracellular domain (ECD) analyte, alone or in combination with other analytes, in body fluid samples |
| 11/27/2003 | US20030219841 Method and reagent for the detection of apoptotic cells and of a protease activated during apoptosis |
| 11/27/2003 | US20030219840 Detecting or identifying proteins which can be used as diagnostic markers for prostate cancer proteins |
| 11/27/2003 | US20030219838 Polypeptide analyses using stable isotope labeling |
| 11/27/2003 | US20030219837 Integrin ligand |
| 11/27/2003 | US20030219836 Prognosticating probability of pregnancy via selectin concentration; in vitro fertilization |
| 11/27/2003 | US20030219835 Using cd antigen 16b to diagnose urogenital disorders |
| 11/27/2003 | US20030219833 Assay devices and methods of analyte detection |
| 11/27/2003 | US20030219832 Administered or coadministered with retinoid drugs to prevent or ameliorate toxicity or side effects caused by retinoids or vitamin A or vitamin A precursors |
| 11/27/2003 | US20030219831 Split-hybrid system |
| 11/27/2003 | US20030219827 Comprises immunoglobulins which bind FMS-related tyrosine kinase 3 (Flt3) receptor for diagnosis and treatment of cancer; immunotherapy |
| 11/27/2003 | US20030219826 Comprises amino acid sequence for treating arthritic, inflammatory and apoptosis disorders; mimetics |
| 11/27/2003 | US20030219825 High throughput method for screening candidate compounds for biological activity |
| 11/27/2003 | US20030219824 High throughput screening method and apparatus |
| 11/27/2003 | US20030219822 Biosensor and method |
| 11/27/2003 | US20030219820 Using differential scanning calorimetry to monitor hydrophobic, covalent, ionic, or hydrogen bonding interactions associated with proteins and/or polynucleotides under heated conditions; high throughput assay |
| 11/27/2003 | US20030219818 Evaluating patient response to antiproliferative/antitumor agents; immunotherapy |
| 11/27/2003 | US20030219817 Preparing and screening immunoglobulin libraries; analyzing binding activity of affinity pairs; mimetic for treatment of autoimmune, cancer, viral and asthma disorders |
| 11/27/2003 | US20030219816 Composite microarray slides |
| 11/27/2003 | US20030219812 Methods and devices for obtaining and assaying mammary fluid samples for evaluating breast diseases, including cancer |
| 11/27/2003 | US20030219811 Comprises nucleotide sequences for diagnosing tuberculosis infection and mycobacterial infections |
| 11/27/2003 | US20030219802 Diagnosis and treatment of osteosarcoma |
| 11/27/2003 | US20030219800 Preparing transgenic cells using microarrays comprised of positionally fixed nucleic acids; genetic engineering; high-throughput assay |
| 11/27/2003 | US20030219797 Statistical modeling to analyze large data arrays |
| 11/27/2003 | US20030219796 Method of testing for allergic disease |
| 11/27/2003 | US20030219795 Identifying modulators of tumor suppressor genes; antitumor/antiproliferative/anticarcinogenic agents |
| 11/27/2003 | US20030219789 36P6D5: secreted tumor antigen |
| 11/27/2003 | US20030219784 Using nucleic acid based bioassay to determine quality of grains |
| 11/27/2003 | US20030219782 Identifying agents which modulate sphingolipid metabolism; drug screening; antiproliferative agents; diagnosing muscular and cancer disorders |
| 11/27/2003 | US20030219780 Methods for the preparation of chemically misaminoacylated tRNA via protective groups |